drugset / Trial / NCT02264028
Metabolism and Pharmacokinetics of [14C]-DK-AH 269 CL in 12 Healthy Male Volunteers
RandomizedParallel-groupOpen-labelTreatment
Summary
* To investigate absorption, metabolism and excretion of \[14C\]-DK-AH 269 CL after oral and intravenous administration in healthy volunteers * To assess the safety and tolerability of DK-AH 269 CL after oral and intravenous administration to healthy volunteers
Timeline
- Start
- 2004-03
- Primary completion
- 2004-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | [14C]-DK-AH 269 CL | Unknown | 5 mg | Intravenous |
| Comparator | [14C]-DK-AH 269 CL | Unknown | 10 mg | Intravenous |
Indications
No indication recorded.